Advisory Services Network, LLC Avid Bioservices, Inc. Transaction History

Advisory Services Network, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.64 - $9.56 $231 - $478	50 New	50 $0
Q1 2023 May 17, 2023	SELL	$13.48 - $18.79 $99,415 - $138,576	-7,375 Reduced 33.09%	14,912 $279,000
Q4 2022 Feb 13, 2023	SELL	$12.61 - $18.74 $15,762 - $23,424	-1,250 Reduced 5.31%	22,287 $306,000
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $107,310 - $142,520	-7,000 Reduced 22.92%	23,537 $450,000
Q1 2022 May 23, 2022	BUY	$16.63 - $27.73 $507,830 - $846,791	30,537 New	30,537 $622,000
Q3 2021 Nov 05, 2021	SELL	$19.05 - $28.32 $95,878 - $142,534	-5,033 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$18.93 - $25.65 $95,274 - $129,096	5,033 New	5,033 $129,000
Q1 2021 May 24, 2021	SELL	$11.86 - $21.77 $60,652 - $111,331	-5,114 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.53 - $8.6 $33,394 - $43,980	5,114 New	5,114 $39,000
Q2 2020 Aug 10, 2020	SELL	$4.11 - $6.78 $32,181 - $53,087	-7,830 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.15 - $7.39 $24,664 - $57,863	7,830 New	7,830 $40,000

209

67.1M

216K

4.6K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.